Multiple EMT-inducing transcription factors, such as TWIST1, SNAIL1/2, and ZEB1/2, may be expressed to drive breast cancer cells to undergo EMT and produce increased invasion, metastasis, and resistance to therapies, including immunotherapy. The gene discussed is ZEB1; the disease is breast carcinoma.